Placeholder Image

Subtitles section Play video

  • Merck said on Monday it will scrap development of its to co vid 19 vaccines.

  • The drugmaker said early trials showed both vaccines produced immune responses that were inferior to those seen in people who had recovered from Cove in 19 and those report for other coronavirus vaccines.

  • Merck will record pretax charge for the two vaccines in the fourth quarter.

  • The new sent its shares down about 1% in early trading Monday.

  • Mark was a late comer in the race.

  • To begin with, it acquired one vaccine candidate by buying Austrian vaccine maker Theme Assed Bioscience.

  • It developed the other one with a nonprofit research organization.

  • Rivals Pfizer and its German partner Beyond Tech as well as Madonna, have already produced tens of millions of doses that have been administered globally.

  • Others, like Johnson and Johnson and AstraZeneca are racing to develop safe and effective vaccines to protect against the virus.

  • Merck says it will now focus pandemic research on treatments.

  • It expects to produce early data on an experimental Orel antiviral by the end of March.

Merck said on Monday it will scrap development of its to co vid 19 vaccines.

Subtitles and vocabulary

Operation of videos Adjust the video here to display the subtitles

B2 produced early research johnson nonprofit monday

Merck ends COVID vaccine program

  • 8 1
    林宜悉 posted on 2021/01/25
Video vocabulary